PARP1 and bladder transitional cell carcinoma: This phenomenon was recently shown for lysine-specific methyltransferase 2C (KMTC) in BLCA, whereupon lower expression led to the downregulation of several genes involved in the DNA damage repair and eventually to synthetic lethality with the PARP inhibitor Olaparib [37].